Cholecystokinin 发表于 2025-3-23 13:45:36

http://reply.papertrans.cn/1/71/7095/7095-11.png

Laconic 发表于 2025-3-23 16:55:57

http://reply.papertrans.cn/1/71/7095/7095-12.png

抱负 发表于 2025-3-23 20:49:30

http://reply.papertrans.cn/1/71/7095/7095-13.png

aesthetic 发表于 2025-3-24 01:03:27

Submitted on: 29 March 2024.
Revised on: 18 May 2024.
Accepted on: 24 June 2024.

___________________Current Treatment Options in Neurology

转换 发表于 2025-3-24 02:29:46

Submitted on: 26 June 2005.
Revised on: 30 August 2005.
Accepted on: 09 October 2005.

___________________Current Treatment Options in Neurology

MODE 发表于 2025-3-24 07:23:42

http://reply.papertrans.cn/1/71/7095/7095-16.png

炸坏 发表于 2025-3-24 10:43:28

Submitted on: 14 June 2016.
Revised on: 31 July 2016.
Accepted on: 26 September 2016.

___________________Current Treatment Options in Neurology

plasma 发表于 2025-3-24 16:27:44

Submitted on: 28 October 2008.
Revised on: 24 November 2008.
Accepted on: 27 December 2008.

___________________Current Treatment Options in Neurology

follicle 发表于 2025-3-24 20:13:13

http://reply.papertrans.cn/1/71/7095/7095-19.png

Congregate 发表于 2025-3-25 03:01:13

Submitted on: 05 May 2016.
Revised on: 16 July 2016.
Accepted on: 22 August 2016.

___________________Current Treatment Options in Neurology
页: 1 [2] 3 4
查看完整版本: SCIE期刊Current Treatment Options in Neurology 2024/2025影响因子:1.863 (CURR TREAT OPTION NE) (1092-8480). (CLINICAL NEUROLOG